Marshall Wace, LLP Vor Biopharma Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 81,114 shares of VOR stock, worth $57,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,114
Previous 76,314
6.29%
Holding current value
$57,590
Previous $180,000
55.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VOR
# of Institutions
73Shares Held
47.9MCall Options Held
1.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA22.7MShares$16.2 Million0.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.46MShares$4.58 Million0.26% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$4.52 Million2.98% of portfolio
-
Laurion Capital Management LP New York, NY2.53MShares$1.79 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.39 Million0.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $27M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...